hC Bioscience
ClosedCambridge, United States · Founded 2021 · $40.0M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 11–50
- Founded
- 2021
- Business Model
- B2B
- Website
- hcbioscience.com
- Total Funding
- $40.0M
- Last Round
- $16.0M Series ANov 2022
- Rounds
- 2
About
Develops tRNA-based therapeutics to restore protein function for genetically defined diseases.
Summary
hC Bioscience is a Biotech company based in Cambridge, United States, founded in 2021. It has raised $40.0M in total across 2 rounds, most recently a $16.0M Series A round in Nov 2022. Investors include ARCH Venture Partners, Takeda (JP) and 8VC.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Nov 2022
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...
BridgeBio makes targeted treatments for genetic diseases.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...